Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.
Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.
复制标题
DOI:
10.1016/j.stem.2012.02.005
复制
发表时间:
2012-03-02
期刊:
影响因子:
23.9
通讯作者:
Karp, Jeffrey M.
中科院分区:
文献类型:
--
作者:
Ranganath, Sudhir H.;Levy, Oren;Inamdar, Maneesha S.;Karp, Jeffrey M.
The broad repertoire of secreted trophic and immunomodulatory cytokines produced by mesenchymal stem cells (MSCs), generally referred to as the MSC secretome, has considerable potential for the treatment of cardiovascular disease. However, harnessing this MSC secretome towards meaningful therapeutic outcomes is challenging due to limited control on cytokine production following transplantation. This review outlines current understanding of the MSC secretome as a therapeutic for treatment of ischemic heart disease. We discuss ongoing investigative directions aimed at improving cellular activity and characterizing the secretome and its regulation in greater detail. Finally, we provide insights and perspectives for future development of the MSC secretome as a therapeutic tool.
登录
查看更多内容
影响因子:
13.6
作者:
Ankrum J;Karp JM
通讯作者:
Karp JM
影响因子:
24
作者:
Hare, Joshua M.;Traverse, Jay H.;Henry, Timothy D.;Dib, Nabil;Strumpf, Robert K.;Schulman, Steven P.;Gerstenblith, Gary;DeMaria, Anthony N.;Denktas, Ali E.;Gammon, Roger S.;Hermiller, James B., Jr.;Reisman, Mark A.;Schaer, Gary L.;Sherman, Warren
通讯作者:
Sherman, Warren
影响因子:
12.4
作者:
Francois, Moira;Romieu-Mourez, Raphaelle;Galipeau, Jacques
通讯作者:
Galipeau, Jacques
影响因子:
4
作者:
Bassaneze, Vinicius;Barauna, Valerio Garrone;Krieger, Jose Eduardo
通讯作者:
Krieger, Jose Eduardo
影响因子:
3.7
作者:
Danoviz ME;Nakamuta JS;Marques FL;dos Santos L;Alvarenga EC;dos Santos AA;Antonio EL;Schettert IT;Tucci PJ;Krieger JE
通讯作者:
Krieger JE